小时 | 讲者 | 演讲标题 | 讲稿摘要 | 数字 |
08:30 | Maximizing safety for facial injectable procedures: arterial wall penetration forces of needles versus cannulas | 88236 | ||
08:50 | Purity as a key differentiator for Xeomin vs. conventional BoNT-A formulations | 88237 | ||
09:10 | A new paradigm for Ultherapy: see-plan-treat | 88238 | ||